Alcon (NYSE:ALC) shares dipped before hours today on second-quarter results that missed the consensus earnings forecast. The Geneva, Switzerland-based company posted losses of -$422 million, or -86¢ per share, on sales of $1.2 billion for the three months ended June 30, 2020, for an 8.2% bottom-line slide on a sales decline of -36.2%. Adjusted to exclude […]
Vision
The 18 most innovative medical devices of 2020
The Galien Foundation recently announced nominees for most innovative medical devices for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical and technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien process, we are honored […]
Second Sight Medical schedules auction of its assets
The assets of Second Sight Medical (NSDQ:EYES) are going up for auction on June 25. The developer and manufacturer of implantable visual prosthetics for blind individuals created the only FDA-approved implantable visual prosthetic treatment for severe retinitis pigmentosa. The company said in March that it was winding down its operations amid the financial shock of the COVID-19 pandemic. […]
Cochlear wins FDA approval to lower age to implant to 9 months
Cochlear Ltd. (ASX:COH) has received FDA approval to lower the age of cochlear implantation to nine months for children. The new approval lowers the age from the original 12 months for children with bilateral, profound sensorineural hearing loss. Cochlear implants have been FDA approved for use in children since 1990. “In light of all that has […]
Mojo Vision developing ‘smart’ contact lens
Mojo Vision is working with the FDA to develop a smart contact lens to help people with low vision. The lens overlays real-time contrast and lighting enhancements with zoom functionality and recently won FDA breakthrough device designation. “Receiving the Breakthrough Device Designation is a significant step in our research and development process. We look forward […]
J&J Vision launches Tecnis Toric II intraocular lens in U.S.
Johnson & Johnson (NYSE:JNJ) Vision announced that, after winning FDA approval, it launched the Tecnis Toric II one-piece intraocular lens (IOL) to treat astigmatism in cataract patients. The Tecnis Toric II IOL is Johnson & Johnson Vision’s first approved product within the Tecnis Toric II platform, which offers more surface texture and friction on IOL haptics, […]
FDA approves CooperVision’s contact lens to slow nearsightedness in kids
The FDA has approved the first contact lens indicated to slow the progression of nearsightedness in children between the ages of 8 and 12 years old. The MiSight contact by CooperCompanies’ (NYSE:COO) CooperVision lens is a single-use, disposable, soft contact lens that is discarded at the end of each day and is not intended to be worn […]
Second Sight device restores visual perception in blind
Researchers at UCLA Health have surgically implanted blind patients with the Second Sight Orion device to improve their visual perception. The Orion device is designed to boost the ability to navigate by restoring their ability to perceive objects and movement. The device converts images captured by a tiny video camera on top of sunglasses into […]
iStar announces $44.2m Series C funding
iStar Medical said today that it completed a Series C financing round worth more than $44 million. Wavre, Belgium-based iStar plans to put the $44.2 million (€40 million) toward developing its MINIject micro-invasive glaucoma surgery (MIGS) device for sale in the U.S. and Europe. MINIject is designed to reduce intraocular pressure by enhancing aqueous humour […]
Sight Sciences raises $31m in Series D funding
Sight Sciences said today that it closed a Series D funding round of more than $30 million. The financing, led by KCK Group, totaled $31 million for the Menlo Park, Calif.-based company that specializes in devices for micro-invasive glaucoma surgery (MIGS) and in treatments for dry eye disease. The company initially said it had pulled […]
FDA approves Alcon’s AcrySof IQ PanOptix trifocal IOL
Alcon (NYSE:ALC) said today that it won FDA approval for its AcrySof IQ PanOptix trifocal intraocular lens and is preparing an initial commercial launch for the device. The Fort Worth, Texas-based company’s AcrySof IQ PanOptix device is the first and only trifocal device in the U.S. for patients undergoing cataract surgery. It’s designed to provide […]
